GlassScriptPhysician profile
Reham Haroun
NPI 1053769299
$3,884.17
in general payments reported to CMS, 2019-2025
9 companies · $411 in 2025
The $411 reported for 2025 was more than what 77% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $414 · 2023: $203 · 2024: $2,591 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,830 · Travel and Lodging: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,829.73 |
| Travel and Lodging | $1,375.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,205.59 | 2022-2025 | Ruby Coil, Indigo System |
| Sirtex Medical INC | $465.84 | 2023-2025 | Sir-Spheres Microspheres |
| Recor Medical INC | $295.10 | 2024 | Paradise Renal Denervation System |
| Inari Medical, INC. | $276.96 | 2022 | |
| Bard Access Systems, INC. | $265.25 | 2021 | |
| Boston Scientific Corporation | $236.46 | 2024 | Spaceoar Vue System - 10ml, Therasphere Y90 Glass Microspheres 10 Gbq |
| Terumo Medical Corporation | $94.60 | 2024 | Azur Cx Detachable |
| Paratek Pharmaceuticals, INC. | $23.71 | 2025 | Nuzyra |
| Teleflex LLC | $20.66 | 2025 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reham Haroun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.